[Form 4] ZIMMER BIOMET HOLDINGS, INC. Insider Trading Activity

Rhea-AI Filing Summary

Insider transaction disclosed for ZIMMER BIOMET HOLDINGS, INC. (ZBH). The reporting person, Sang Yi, Group President, Asia Pacific and an officer and director, reported a sale of 1,200 shares of common stock on 09/11/2025 at a price of $103.585 per share. After the sale, the filing shows 18,584 shares beneficially owned by the reporting person. The filing also notes that the reported beneficial ownership includes 160 shares acquired under the Employee Stock Purchase Plan on June 30, 2025. The Form 4 was signed by an attorney-in-fact on 09/15/2025.

Positive

• Complete transaction disclosure including date, price, quantity, and resulting beneficial ownership
• ESPP purchase disclosure showing 160 shares acquired on June 30, 2025 included in total ownership
• Form signed under power of attorney, indicating procedural compliance

Negative

• Insider sale of 1,200 shares which reduces the reporting person\'s holdings to 18,584 shares
• No statement of a 10b5-1 plan or reason for the sale is provided in the filing

Insights

Securities Analyst

TL;DR: Officer sold a small block of shares; ownership remains material but transaction appears routine.

The sale of 1,200 shares at $103.585 reduces the reporting person\'s stake to 18,584 shares. The filing explicitly records a June 30 ESPP purchase of 160 shares. This is a standard Section 16 disclosure showing a single non-derivative sale by an officer/director. There is no information in the filing about the reason for the sale, any 10b5-1 plan, or any related change to employment or control. For investors, the item is a routine insider sale rather than a corporate event.

Corporate Governance Expert

TL;DR: Disclosure is complete for the transaction; no indication of governance issues in this filing.

The Form 4 identifies the reporting person\'s roles and provides transaction details: date, transaction code (S for sale), quantity, price, and resulting beneficial ownership. It also discloses the inclusion of ESPP-acquired shares. The signature is via a previously filed power of attorney. The document contains the required elements for transparency under Section 16 but does not indicate any material governance actions or policy changes.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Yi Sang

(Last) (First) (Middle)

345 E. MAIN STREET

(Street)

WARSAW IN 46580

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
ZIMMER BIOMET HOLDINGS, INC. [ ZBH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Group President, Asia Pacific

3. Date of Earliest Transaction (Month/Day/Year)
09/11/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/11/2025		S		1,200	D	$103.585	18,584(1)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Includes 160 shares acquired under the Employee Stock Purchase Plan on June 30, 2025.

	/s/ Matthew R. St. Louis, Attorney-in-Fact for Sang Yi (power of attorney previously filed)	09/15/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Sang Yi report in the Form 4 for ZBH?

The Form 4 reports a sale of 1,200 shares of ZBH common stock on 09/11/2025 at $103.585 per share, leaving 18,584 shares beneficially owned.

How many shares does Sang Yi own after the reported transaction?

The filing states the reporting person beneficially owns 18,584 shares following the sale.

Were any shares recently acquired by Sang Yi disclosed?

Yes, the filing includes 160 shares acquired under the Employee Stock Purchase Plan on June 30, 2025 as part of the beneficial ownership total.

When was the Form 4 signed and by whom?

The Form 4 is signed on 09/15/2025 by Matthew R. St. Louis as attorney-in-fact for Sang Yi (power of attorney previously filed).

Does the filing indicate a 10b5-1 trading plan for the sale?

The Form 4 does not indicate that the transaction was made pursuant to a 10b5-1 plan.